Initial Outcome After Selective Intraarterial Radionuclide Therapy with Yttrium-90 Microspheres as Salvage Therapy for Unresectable Metastatic Liver Disease-Reference-Cited by-同舟云学术

Initial Outcome After Selective Intraarterial Radionuclide Therapy with Yttrium-90 Microspheres as Salvage Therapy for Unresectable Metastatic Liver Disease

Published:2013-09 Issue:7 Volume:28 Page:534-540
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Turkmen Cuneyt¹,Ucar Adem²,Poyanli Arzu²,Vatankulu Betul¹,Ozkan Gozde¹,Basaran Mert³,Serin Kursat⁴,Sanli Yasemin¹,Adalet Isik¹

Affiliation:

1. Department of Nuclear Medicine, Istanbul University, Istanbul, Turkey.

2. Department of Radiology, Istanbul University, Istanbul, Turkey.

3. Department of Medical Oncology, Istanbul University, Istanbul, Turkey.

4. Department of General Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2012.1455

Reference33 articles.

1. Surgical treatment of liver metastases

2. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience

3. Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases: A Single Institution Experience

4. Unresectable Chemorefractory Liver Metastases: Radioembolization with90Y Microspheres—Safety, Efficacy, and Survival

5. Hepatic Yttrium-90 Radioembolization of Chemotherapy-refractory Colorectal Cancer Liver Metastases

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on ⁹⁰Y Selective Internal Radiation Therapy Planning;Cancer Biotherapy and Radiopharmaceuticals;2024-06-01

2. Gastro-Enteric-Pancreatic Neuroendocrine Tumor Treatment;PET Clinics;2023-04

3. Surgical and survival outcomes after robotic and open pancreaticoduodenectomy with positive margins;Journal of the Chinese Medical Association;2021-07

4. Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?;Nuclear Medicine Communications;2020-09-15

5. Minimal-activity PET/CT for efficacy control after SIRT (MAPECSI) – clinical implementation of a resource-saving, liver-focused protocol;Nuklearmedizin;2019-08-14